Response to the Letter to the Editor Regarding “Serologic Survey of IgG Against SARS-CoV-2 Among Hospital Visitors Without a History of SARS-CoV-2 Infection in Tokyo, 2020-2021”Comment Published on 2023-02-052024-09-05 Journal: Journal of Epidemiology [Category] update2024, [키워드] COVID-19 hospital visitors. IgG seroprevalence SARS-CoV-2 Tokyo [DOI] 10.2188/jea.JE20220202 PMC 바로가기 [Article Type] Comment
Serologic Survey of IgG Against SARS-CoV-2 Among Hospital Visitors Without a History of SARS-CoV-2 Infection in Tokyo, 2020–2021도쿄에서 SARS-CoV-2 감염 이력이 없는 병원 방문자 중 SARS-CoV-2에 대한 IgG의 혈청학적 조사, 2020-2021Original Article Published on 2022-02-052022-09-12 Journal: Journal of Epidemiology [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] 95% CI 95% confidence interval Against age All participants anti–SARS-CoV-2 IgG antibody blood collection Capital chemiluminescence immunoassay China confirmed cases coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19-related symptom COVID-19-related symptoms cross-sectional cross-sectional study diagnosed ENhance Epidemic exhibited high risk history hospital hospital visitors iFlash IgG IgG seroprevalence individual Infection Japan participant Patient positive result Randomly Respiratory Coronavirus Result SARS-CoV-2 SARS-CoV-2 epidemic SARS-COV-2 infection selected serologic seropositive Seroprevalence serum serum sample serum samples Sex Shenzhen Shenzhen YHLO Biotech survey the SARS-CoV-2 Tokyo Visitor was tested [DOI] 10.2188/jea.JE20210324 PMC 바로가기 [Article Type] Original Article
The prevalence of SARS-CoV-2 antibodies in triage-negative patients and staff of a fertility setting from lockdown release throughout 2020Original Article Published on 2021-07-272022-10-31 Journal: Human Reproduction Open [Category] COVID-19, [키워드] acute respiratory syndrome age analyzed antibodies antibody ART ART patient assisted reproduction Asymptomatic blood sample Care carried chemiluminescence CLIA Cohort collected data Consensus coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 domain Evidence exhibiting fertility unit form Generalizability groups HCW HCWs Health care worker highest IgG IgG seroprevalence IgM IgM and IgG immunized immunoassay immunoassays increase in Infection lack limit lockdown measure Measures men molecular test nasopharyngeal swabs no significant difference Older age pandemic Patient PCR testing positive positive molecular test positive result positive serology Prevalence prevalence rate Protective reproductive Research resource risk S1 and S2 SARS-CoV-2 SARS-CoV-2 antibodies SARS-CoV-2 antibody SARS-COV-2 infection SARS-CoV-2 prevalence trends serological serological test Serological testing severe acute respiratory syndrome coronavirus 2 significantly higher Spike protein study period the SARS-CoV-2 translation Trial vaccination virus virus spike protein was recorded were assessed women [DOI] 10.1093/hropen/hoab028 PMC 바로가기 [Article Type] Original Article